289 related articles for article (PubMed ID: 9203661)
21. Molecular analysis of genes encoding outer surface protein C (OspC) of Borrelia burgdorferi sensu lato: relationship to ospA genotype and evidence of lateral gene exchange of ospC.
Jauris-Heipke S; Liegl G; Preac-Mursic V; Rössler D; Schwab E; Soutschek E; Will G; Wilske B
J Clin Microbiol; 1995 Jul; 33(7):1860-6. PubMed ID: 7665660
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of outer surface proteins A and C by individual Borrelia burgdorferi in different genospecies.
Fingerle V; Laux H; Munderloh UG; Schulte-Spechtel U; Wilske B
Med Microbiol Immunol; 2000 Nov; 189(2):59-66. PubMed ID: 11138638
[TBL] [Abstract][Full Text] [Related]
23. Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine.
Edelman R; Palmer K; Russ KG; Secrest HP; Becker JA; Bodison SA; Perry JG; Sills AR; Barbour AG; Luke CJ; Hanson MS; Stover CK; Burlein JE; Bansal GP; Connor EM; Koenig S
Vaccine; 1999 Feb; 17(7-8):904-14. PubMed ID: 10067697
[TBL] [Abstract][Full Text] [Related]
24. A recombinant vaccine for Lyme disease.
Wallich R; Kramer MD; Simon MM
Behring Inst Mitt; 1994 Dec; (95):106-8. PubMed ID: 7755503
[TBL] [Abstract][Full Text] [Related]
25. Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi.
Luke CJ; Huebner RC; Kasmiersky V; Barbour AG
Vaccine; 1997; 15(6-7):739-46. PubMed ID: 9178476
[TBL] [Abstract][Full Text] [Related]
26. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.
Fawcett PT; Rose CD; Budd SM; Gibney KM
Clin Diagn Lab Immunol; 2001 Jan; 8(1):79-84. PubMed ID: 11139199
[TBL] [Abstract][Full Text] [Related]
27. Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites.
Gern L; Rais O; Capiau C; Hauser P; Lobet Y; Simoen E; Voet P; Pêtre J
Immunol Lett; 1994 Mar; 39(3):249-58. PubMed ID: 8034340
[TBL] [Abstract][Full Text] [Related]
28. Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B.
Fikrig E; Tao H; Chen M; Barthold SW; Flavell RA
J Clin Invest; 1995 Oct; 96(4):1706-14. PubMed ID: 7560061
[TBL] [Abstract][Full Text] [Related]
29. Protective immunity is induced by a Borrelia burgdorferi mutant that lacks OspA and OspB.
Hughes CA; Engstrom SM; Coleman LA; Kodner CB; Johnson RC
Infect Immun; 1993 Dec; 61(12):5115-22. PubMed ID: 8225588
[TBL] [Abstract][Full Text] [Related]
30. Vaccination as a modality to prevent Lyme disease. A status report.
Wormser GP
Infect Dis Clin North Am; 1999 Mar; 13(1):135-48, vii. PubMed ID: 10198796
[TBL] [Abstract][Full Text] [Related]
31. Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA.
Ding W; Huang X; Yang X; Dunn JJ; Luft BJ; Koide S; Lawson CL
J Mol Biol; 2000 Oct; 302(5):1153-64. PubMed ID: 11183781
[TBL] [Abstract][Full Text] [Related]
32. Genetic heterogenity of the genes coding for the outer surface protein C (OspC) and the flagellin of Borrelia burgdorferi.
Jauris-Heipke S; Fuchs R; Motz M; Preac-Mursic V; Schwab E; Soutschek E; Will G; Wilske B
Med Microbiol Immunol; 1993 Mar; 182(1):37-50. PubMed ID: 8098841
[TBL] [Abstract][Full Text] [Related]
33. Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of lyme borreliosis.
Magnarelli LA; Fikrig E; Padula SJ; Anderson JF; Flavell RA
J Clin Microbiol; 1996 Feb; 34(2):237-40. PubMed ID: 8788993
[TBL] [Abstract][Full Text] [Related]
34. Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks.
Ohnishi J; Piesman J; de Silva AM
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):670-5. PubMed ID: 11209063
[TBL] [Abstract][Full Text] [Related]
35. Evasion of protective immunity by Borrelia burgdorferi by truncation of outer surface protein B.
Fikrig E; Tao H; Kantor FS; Barthold SW; Flavell RA
Proc Natl Acad Sci U S A; 1993 May; 90(9):4092-6. PubMed ID: 7683420
[TBL] [Abstract][Full Text] [Related]
36. Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC.
Gilmore RD; Kappel KJ; Dolan MC; Burkot TR; Johnson BJ
Infect Immun; 1996 Jun; 64(6):2234-9. PubMed ID: 8675332
[TBL] [Abstract][Full Text] [Related]
37. Consensus sequence on the genes encoding the major outer surface proteins (OspA and OspB) of Borrelia garinii isolate.
Wang J; Masuzawa T; Komikado T; Yanagihara Y
Microbiol Immunol; 1997; 41(2):83-91. PubMed ID: 9087950
[TBL] [Abstract][Full Text] [Related]
38. Access of antibody or trypsin to an integral outer membrane protein (P66) of Borrelia burgdorferi is hindered by Osp lipoproteins.
Bunikis J; Barbour AG
Infect Immun; 1999 Jun; 67(6):2874-83. PubMed ID: 10338494
[TBL] [Abstract][Full Text] [Related]
39. Activation of monocytes by three OspA vaccine candidates: lipoprotein OspA is a potent stimulator of monokines.
Häupl T; Landgraf S; Netusil P; Biller N; Capiau C; Desmons P; Hauser P; Burmester GR
FEMS Immunol Med Microbiol; 1997 Sep; 19(1):15-23. PubMed ID: 9322065
[TBL] [Abstract][Full Text] [Related]
40. Vaccination against lyme disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses.
Chang Y; Novosol V; McDonough SP; Chang CF; Jacobson RH; Divers T; Quimby FW; Shin S; Lein DH
Vaccine; 1999 Oct; 18(5-6):540-8. PubMed ID: 10519945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
